Lane Rolling MD, Virologist, Trauma Surgeon and Military Veteran Joins Nitric Oxide Innovations as Its Chief Science Officer

2-Feb-2021 12:30 PM EST, by Nitric Oxide Innovations, LLC

Newswise — Austin, TX…February 2, 2021. ,Dr. Nathan S. Bryan, Ph.D., Founder and CEO of Nitric Oxide Innovations, announced today that Dr. Rolling will be joining his company as Chief Science Officer (CSO).

“We are honored and excited to have Dr. Rolling join our team.  His expertise in virology and infectious disease combined with his international recognition as a trusted physician will help us inform and educate the African American community on this important study and lead our efforts even after the clinical study, says Dr. Bryan. 

“Dr. Lane Rolling, M.D. is a well-known infectious disease expert, trauma surgeon and military veteran. Dr. Rolling, is a certified chemical and biological warfare expert who is dedicated to saving lives and eradicating the coronavirus is also a member of COVID-19 Health Care Task Force of the Congressional Black Caucus. His mission is driven by his passion to change today’s COVID-19 statistics to create a brighter tomorrow, especially for the African American community,” Bryan said.   

Rolling said, “I am very excited to join NOi.  We have known for decades about the health disparities of African Americans. Since COVID-19, it has become even more clear that more African Americans are hospitalized and die from COVID-19 than any other community. No one has addressed this specific concern until now. NOi’s NOviricid drug trial in African Americans recently diagnosed with COVID is a significant change in COVID19 treatment. This drug has the potential to save the black race.” 

“Nearly 70% of blacks do not want and do not trust the COVID vaccine, and with good reason.  A safe and effective drug therapy that can eliminate and shorten Covid-19 symptoms is a better solution for African Americans.  I just learned of this study and the patented nitric oxide technology. I was shocked that this study has not received media attention so I’m excited to help inform the masses on this important technology and study.  This may be the most important project of my lifetime,” Rolling said.”  

NOi has received Investigational New Drug (IND #150758) clearance as part of the Coronovirus Treatment Acceleration Program (CTAP) from the U.S. FDA to conduct a Phase 2b/3a outpatient clinical study testing the safety and efficacy of its new drug, NOviricid, 30 mg time released sodium nitrite dosing in an oral lozenge. NOviricid is the first oral Nitric Oxide (NO) generating drug to be clinically tested to treat African Americans diagnosed with COVID-19.  www.clinicaltrials.gov (NCT04601077)

NOviricid offers a fast acting, Nitric Oxide therapeutic, with proven vasodilatory and anti-viral properties, targeting the effects of the novel Coronavirus. NOviricid is a proactive treatment, to be administered at the early onset of symptoms to prevent the rapid progression of the virus, improve recovery and survival of African Americans or anyone who is symptomatic. NOviricid promises an easily administered, safe, affordable and effective treatment.

To date, the COVID-19 pandemic has infected nearly 100 million people worldwide and is responsible for over 2 million deaths. In the U.S., African Americans are one of the most affected, high-risk populations. According to the Centers for Disease Control and Prevention (CDC), African Americans experience a 2.8x higher infection rate, a 4.7x higher hospitalization rate and 2.1x higher death rate than Caucasians. Those with comorbidities such as hypertension, diabetes, obesity, history of smoking, kidney disease and respiratory illnesses are most at risk for infection and rapid progression of the disease.  

“Everything we have learned about COVID-19 over the past 12 months reveals that diminished nitric oxide production in patients is what is thought to be responsible for the increased risk of infection and rapid disease progression. This applies directly to the African American population, which often suffers from diminished nitric oxide production. A lack of nitric oxide explains the multi-system disease and dysfunction that persists long after the active infection is gone, including increased risk of blood clots, endothelitis, kidney and lung dysfunction. Restoration of nitric oxide appears to be a very safe and effective solution,” said Dr. Bryan. 

About Nitric Oxide Innovations, LLC:

Founded in 2018, Nitric Oxide Innovations, LLC., is a clinical stage biotechnology company established to commercialize clinically and scientifically proven NO based technologies for a wide range of human diseases. 

 NOI’s mission is to be the industry leader and innovator of nitric oxide-based therapeutics or the safe and effective treatments of a variety of human diseases. Focusing on proven nitric oxide patented technology, along with patented delivery systems, Nitric Oxide Innovations LLC will develop novel drug therapies ranging from topical drug deliveries to oral formulations for specific drug indications where safety and efficacy are already established. These new nitric oxide therapies will address pulmonary hypertension, non-obstructive but ischemic coronary artery disease (INOCA), heart failure with preserved ejection fraction ( HFpEF) and chronic wound/ulcer therapy.



Filters close

Showing results

110 of 6101
Released: 30-Jul-2021 2:05 PM EDT
Thinking Impaired in 60% of COVID-19 Survivors, Study Finds
University of Texas Health Science Center at San Antonio

In a sample of over 400 older adults in Argentina who had recovered from COVID-19, more than 60% displayed some degree of cognitive impairment, a researcher from The University of Texas Health Science Center at San Antonio reported July 29 at the Alzheimer’s Association International Conference.

Released: 30-Jul-2021 11:50 AM EDT
Support for Government Mandates High and Increasing Over Time, Survey Finds
Rutgers University-New Brunswick

As the coronavirus Delta variant surges throughout the country and mask and vaccine mandates are being considered, a new national survey finds that almost 20 percent of Americans say it is unlikely that they will get the COVID-19 vaccine.

Newswise: How to Play with Your Children in Age-appropriate and Creative Ways When Schools Are Still Closed and Everyone Is Still Stuck at Home
Released: 30-Jul-2021 8:55 AM EDT
How to Play with Your Children in Age-appropriate and Creative Ways When Schools Are Still Closed and Everyone Is Still Stuck at Home
Chulalongkorn University

The COVID-19 situation may have restricted people’s space, but not their imagination. A Chula lecturer has given recommendations to parents who need to spend more time at home on select social activities to enhance children’s development in a safe and age-appropriate way.

Released: 30-Jul-2021 8:30 AM EDT
American Society of Anesthesiologists Strongly Encourages all Health Care Personnel to Get Vaccinated Against COVID-19
American Society of Anesthesiologists (ASA)

Amid the new surge of COVID-19 cases across the U.S., the American Society of Anesthesiologists (ASA), and eight professional societies associated with the specialty, are strongly encouraging the nation’s health care workers and all eligible Americans to get fully vaccinated with one of the COVID-19 vaccines. ASA and the associated societies remind the public that widespread vaccination is the most effective way to reduce illness and death.

Released: 29-Jul-2021 4:45 PM EDT
Which Voices Led Medical Misinformation in the Early Stages of COVID?
University of Cincinnati

In the early and thus far most devastating stages of the COVID-19 pandemic, scientists were at a near loss on how to treat the deadly disease.

Released: 29-Jul-2021 4:40 PM EDT
Half of U.S. Parents May Not Vaccinate Their Youngest Child Against COVID-19
CUNY Graduate School of Public Health and Health Policy

Even as the delta variant of Covid-19 sweeps the globe, leaving those who remain unvaccinated vulnerable, vaccination among adults and teenagers in the United States is stalling, giving rise to concerns over whether parents will vaccinate their young children once vaccines are approved for those under 12 years of age.

Newswise: COVID-19 update: coping with increased cases, breakthrough infections, national masking mandates and vaccine requirements
Released: 29-Jul-2021 4:05 PM EDT
COVID-19 update: coping with increased cases, breakthrough infections, national masking mandates and vaccine requirements
Keck Medicine of USC

Keck Medicine of USC experts speak out on the continued physical and emotional consequences of COVID-19

Released: 29-Jul-2021 3:45 PM EDT
FSMB: Spreading COVID-19 Vaccine Misinformation May Put Medical License at Risk
Federation of State Medical Boards (FSMB)

The Federation of State Medical Boards’ Board of Directors released statement in response to a dramatic increase in the dissemination of COVID-19 vaccine misinformation and disinformation by physicians and other health care professionals on social media platforms, online and in the media.

Newswise: Argonne’s Macal named Fellow of the Society for Computer Simulation International
Released: 29-Jul-2021 2:05 PM EDT
Argonne’s Macal named Fellow of the Society for Computer Simulation International
Argonne National Laboratory

Charles M. “Chick” Macal, a modeling and simulation expert at Argonne, garnered the distinguished title of Fellow of the Society for Computer Simulation International for his 20 years in the field and his recent studies on COVID-19 spread.


Showing results

110 of 6101

close
1.47869